20
Aurobindo Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is BENAZEPRIL HYDROCHLORIDE USP, with a corresponding US DMF Number 19013.
Remarkably, this DMF maintains an Active status since its submission on November 28, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 16, 2022, and payment made on June 15, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II